Condition: Peripheral T Cells Lymphoma (PTCL) · Sponsor: The Lymphoma Academic Research Organisation
This study is a platform trial for the evaluation of new drugs or combination of drugs in relapsed or refractory peripheral T-cell lymphomas. The objective of the study is to generate exploratory data on new drugs or combination of drugs to treat refractory/relapse peripheral T-cells lymphoma to better identify the population of interest and design future correct clinical trials. Primary objectives of the different sub-studies : * phase 1 sub-studies: determine the safety and tolerability of escalating doses of the sub-study treatment * phase 2 sub-studies: identify drugs that will improve significantly the outcome in target patients Secondary objectives of both sub-studies: analyze the response rate, the clinical benefit rate, the progression-free survival, the duration of response, the time to next treatment or death, the overall survival, the rate of transplantation following study treatment and the safety profile of the drugs used
This description comes directly from the study's public registry record.
Clinical Project Manager · +33 4 72 66 93 33 · platform@lysarc.org
Always discuss trial participation with your own doctor first.
| Institut d'Hématologie de Basse Normandie - Service Hématologie (CHU Hôpital Côte de Nacre) | Caen, France | Recruiting |
| CHU Estaing - Service Thérapie Cellulaire et Hématologie Clinique | Clermont-Ferrand, France | Not Yet Recruiting |
| Hôpital Henri Mondor - Unité Hémopathies Lymphoïdes | Créteil, France | Recruiting |
| CHU Dijon Bourgogne - Service Hématologie Clinique | Dijon, France | Recruiting |
| CHU de Grenoble - Service Hématologie | La Tronche, France | Not Yet Recruiting |
| CH du Mans - Centre de Cancérologie de la Sarthe - Service Hématologie | Le Mans, France | Not Yet Recruiting |
| CHU de Lille - Hôpital Claude Huriez - Service des Maladies du Sang | Lille, France | Recruiting |
| Institut Paoli Calmettes - Service Hématologie | Marseille, France | Not Yet Recruiting |
| CHU de Montpellier - Département d'Hématologie Clinique | Montpellier, France | Recruiting |
| CHU de Nantes - Service Hématologie | Nantes, France | Recruiting |
| Hôpital Necker - Service Hématologie Adultes | Paris, France | Recruiting |
| CHU de Bordeaux - Hôpital Haut-Lévêque - Centre François Magendie - Service d'Hématologie et Thérapie Cellulaire | Pessac, France | Not Yet Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07018752